Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Imagenetix, Cymbiotics Inc and Dr Reddy's Laboratories have teamed up to offer the joint health product Celadrin to physicians treating patients with osteoarthritis in India.
Subscribe to our email newsletter
Celadrin, developed by Imagenetix, is a proprietary fatty acid complex useful in promoting joint health. It has been approved for use as a pharmaceutical product in India to help reduce pain and inflammation in patients with joint conditions. In the US, Celadrin is currently available in oral form as a dietary supplement and as an over-the-counter topical cream.
The product has been shown to be safe and effective in several clinical studies. In one study, subjects with knee joint conditions who used Celadrin in cream form showed significant improvement in quality of life measurements such as getting up from a seated position and stair climbing. A similar study determined that patients who took Celadrin orally improved knee range of motion and overall function. Furthermorem participants in the studies exhibited no side effects.
The companies will be marketing Celadrin in India in capsule and topical cream formulations.